According to Aclaris Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.74. In 2022 the company made an earnings per share (EPS) of -$2.35 an increase over its 2021 EPS that were of -$2.89.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.53 | 7.46% |
2022 | -$2.35 | -18.4% |
2021 | -$2.89 | 35.83% |
2020 | -$2.12 | -69.31% |
2019 | -$6.92 | -3.22% |
2018 | -$7.15 | 67.63% |
2017 | -$4.27 | 6.64% |
2016 | -$4.00 | 66.73% |
2015 | -$2.40 |